156 related articles for article (PubMed ID: 20051877)
1. How to protect doxorubicin-induced cardiomyopathy in male albino rats?
Shaker O; Sourour DA
J Cardiovasc Pharmacol; 2010 Mar; 55(3):262-8. PubMed ID: 20051877
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
3. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
5. Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model.
Aupperle H; Garbade J; Schubert A; Barten M; Dhein S; Schoon HA; Mohr FW
Vet Pathol; 2007 Jul; 44(4):494-503. PubMed ID: 17609194
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin modulates imbalance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced cardiotoxicity.
Chen X; Guo Z; Wang P; Xu M
Heart Lung Circ; 2014 Aug; 23(8):772-7. PubMed ID: 24685074
[TBL] [Abstract][Full Text] [Related]
7. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
[TBL] [Abstract][Full Text] [Related]
8. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
9. [Nitric oxide modulates expression of matrix metalloproteinase in asthmatic rats].
Yuan Y; Wang Z; Dong B
Zhonghua Jie He He Hu Xi Za Zhi; 2002 May; 25(5):276-9. PubMed ID: 12133319
[TBL] [Abstract][Full Text] [Related]
10. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
11. Persistent effects of doxorubicin on cardiac gene expression.
Boucek RJ; Miracle A; Anderson M; Engelman R; Atkinson J; Dodd DA
J Mol Cell Cardiol; 1999 Aug; 31(8):1435-46. PubMed ID: 10423342
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
13. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
Martinez ML; Rizzi E; Castro MM; Fernandes K; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Dec; 599(1-3):110-6. PubMed ID: 18930722
[TBL] [Abstract][Full Text] [Related]
14. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.
Carvalho RA; Sousa RP; Cadete VJ; Lopaschuk GD; Palmeira CM; Bjork JA; Wallace KB
Toxicology; 2010 Apr; 270(2-3):92-8. PubMed ID: 20132857
[TBL] [Abstract][Full Text] [Related]
15. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effect of whole fruit extract of pomegranate on doxorubicin-induced toxicity in rat.
Hassanpour Fard M; Ghule AE; Bodhankar SL; Dikshit M
Pharm Biol; 2011 Apr; 49(4):377-82. PubMed ID: 21391840
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase-9 in ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions.
Yamaguchi H; Kidachi Y; Umetsu H; Ryoyama K
Cell Biol Int; 2008 Aug; 32(8):940-9. PubMed ID: 18474440
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
[TBL] [Abstract][Full Text] [Related]
19. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
20. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
